查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1611861

血管补片市场：依材料、应用分类 - 2025-2030 年全球预测

Vascular Patches Market by Material (Biologic Vascular Patches, Synthetic Vascular Patches), Application (Carotid Endarterectomy, Open Repair of Abdominal Aneurysm, Peripheral Vascular Reconstruction) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年血管贴片市场价值为3.9992亿美元，预计到2024年将达到4.3416亿美元，复合年增长率为7.99%，到2030年将达到6.8515亿美元。

血管补片市场是更广泛的医疗设备产业中特别有趣的部分。血管补片用于心血管手术中修復或重组动脉和静脉。它们通常由聚四氟乙烯和聚酯纤维等合成材料或牛心包膜等生物组织製成，在颈动脉切除术和周边搭桥手术等手术中至关重要。对血管补片的需求源于对耐用且生物相容性解决方案的需求，以最大限度地减少术后併发症，例如感染疾病和血栓症。医院、专科诊所和门诊手术中心是主要的最终使用领域。有几个因素推动了这个市场的成长。心血管疾病的增加、人口老化、外科手术的进步以及对微创手术认识的提高正在产生关键影响。随着高度生物相容性并降低感染风险的创新材料的开发，新的机会正在出现，例如涂有抗发炎剂的贴片或使用奈米技术的进步。然而，市场也面临挑战。例如，涂有抗发炎剂或使用奈米技术进步的贴片。然而，先进补丁的高成本，产品核可的监管途径严格，以及因批次不良而导致产品召回的风险。此外，一些地区有限的报销政策可能会抑制市场扩张。创新的关键部分是提高贴片的生物相容性和机械性能，扩展到新型生物分解性材料，以及改进製造技术以降低成本，同时确保安全和品质。为了实现成长，该公司应专注于心血管疾病高发生率的开拓市场的地理扩张，例如亚太地区和拉丁美洲的部分地区。血管补片市场本质上是竞争激烈的，大型参与企业和小型创新企业都渴望取得突破。持续成长需要利用产品开发的前沿研究，同时适应监管要求和不断变化的医疗需求。

主要市场统计
基准年[2023] 3.9992 亿美元
预计年份 [2024] 4.3416亿美元
预测年份 [2030] 6.8515 亿美元
复合年增长率（%） 7.99%

市场动态：揭示快速发展的血管贴片市场的关键市场洞察

供需的动态交互作用正在改变血管补片市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 血管疾病和凝血障碍的盛行率上升
    • 对减少医疗设备毒性的生物相容性材料的需求不断增长
  • 市场限制因素
    • 因补丁不可靠而召回产品
  • 市场机会
    • 组织工程和 3D 技术的进步
    • 人们对干细胞研究和利用干细胞技术生产血管补片的兴趣日益浓厚
  • 市场问题
    • 有关血管补片稳定性的调控问题

波特五力：驾驭血管贴片市场的策略工具

波特的五力框架是了解血管贴片市场竞争格局的关键工具。波特的五力框架描述了评估公司竞争和探索策略机会的清晰方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解血管贴片市场的外部影响

外部宏观环境因素对血管补片市场的表现动态起着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析：了解血管补片市场的竞争格局

对血管贴片市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示自己的竞争定位。该分析揭示了市场集中、细分和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵：血管补片市场供应商的绩效评估

FPNV定位矩阵是评估血管补片市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议：绘製血管补片市场的成功之路

血管贴片市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

该报告对涵盖关键焦点细分市场的市场进行了全面分析。

1. 市场渗透率：详细检视当前市场环境，主要企业的广泛资料，评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有细分市场的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、主要产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策。

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品和地区提供最佳投资机会？

3.塑造市场的关键技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 血管疾病和凝血障碍的盛行率增加
      • 对生物相容性材料以减少医疗设备毒性的需求不断增加
    • 抑制因素
      • 因补丁不可靠而召回的产品案例
    • 机会
      • 组织工程和 3D 技术的进步
      • 人们对干细胞研究和利用干细胞技术生产血管补片的兴趣日益浓厚
    • 任务
      • 有关血管补片稳定性的调控问题
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第六章血管补片市场：依材料分类

  • 介绍
  • 生物血管补片
  • 合成血管补片

第七章血管补片市场：依应用分类

  • 介绍
  • 颈动脉切除术
  • 腹动脉瘤开放式修补术
  • 周围血管重建术
  • 血管搭桥手术

第八章美洲血管补片市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太血管补片市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章欧洲/中东/非洲血管贴片市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Aegis Lifesciences Private Limited
  • Artivion, Inc
  • AVOMA GROUP
  • Axio Biosolutions Pvt Ltd
  • B. Braun SE
  • Baxter International, Inc.
  • Becton, Dickinson and Company
  • Braile Biomedica
  • Celox Medical by Medtrade Products Ltd.
  • CryoLife
  • Edwards Lifesciences Corporation
  • Getinge AB
  • Labcor Laboratorios Ltda.
  • LeMaitre Vascular, Inc.
  • Obex Medical Limited
  • Solinas Medical Inc.
  • Terumo Corporation
  • VUP Medical, as
  • WL Gore & Associates, Inc.
Product Code: MRR-B16853779434

The Vascular Patches Market was valued at USD 399.92 million in 2023, expected to reach USD 434.16 million in 2024, and is projected to grow at a CAGR of 7.99%, to USD 685.15 million by 2030.

The market for vascular patches is a focused segment within the broader medical devices industry. Vascular patches are employed in cardiovascular surgeries to repair or reconstruct arteries and veins. They are typically made from synthetic materials like PTFE, Dacron, or biological tissue such as bovine pericardium, and are crucial in procedures like carotid endarterectomy and peripheral bypass surgery. The necessity of vascular patches emerges from the need for durable and biocompatible solutions that minimize post-surgical complications like infection and thrombosis. Hospitals, specialty clinics, and ambulatory surgical centers represent the primary end-use domains. Several factors drive the growth of this market. The rise in cardiovascular diseases, increasing geriatric population, advancements in surgical procedures, and growing awareness about minimally invasive surgeries are pivotal influences. New opportunities are emerging with the development of innovative materials offering greater biocompatibility and reduced risk of infection; for example, patches coated with anti-inflammatory agents or those benefiting from nanotechnology advancements. However, the market also faces challenges. These include high costs of advanced patches, stringent regulatory pathways for product approvals, and risks of product recalls due to defective batches. Additionally, limited reimbursement policies in some regions might impede market expansion. Key areas for innovation lie in enhancing the biocompatibility and mechanical properties of patches, expanding to novel biodegradable materials, and improving manufacturing techniques that reduce costs while ensuring safety and quality. For growth, companies should focus on geographical expansion in untapped markets with high cardiovascular disease prevalence, such as parts of Asia-Pacific and Latin America. The nature of the vascular patches market is competitive, with both large established players and smaller innovators keen on breakthroughs. Adapting to both regulatory requirements and evolving medical needs while leveraging cutting-edge research for product development will be vital for sustained growth.

KEY MARKET STATISTICS
Base Year [2023] USD 399.92 million
Estimated Year [2024] USD 434.16 million
Forecast Year [2030] USD 685.15 million
CAGR (%) 7.99%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Vascular Patches Market

The Vascular Patches Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of vascular diseases and clotting disorders
    • Growing need for biocompatible material to reduce the toxicity of medical devices
  • Market Restraints
    • Instances of product recall due to reduced reliability of patches
  • Market Opportunities
    • Advancements in tissue engineering and 3D technology
    • Growing interest in stem cell research and the use of stem cell technology for the production of vascular patches
  • Market Challenges
    • Regulatory issues concerning the stability of vascular patches

Porter's Five Forces: A Strategic Tool for Navigating the Vascular Patches Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Vascular Patches Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Vascular Patches Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Vascular Patches Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Vascular Patches Market

A detailed market share analysis in the Vascular Patches Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Vascular Patches Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Vascular Patches Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Vascular Patches Market

A strategic analysis of the Vascular Patches Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Vascular Patches Market, highlighting leading vendors and their innovative profiles. These include Aegis Lifesciences Private Limited, Artivion, Inc, AVOMA GROUP, Axio Biosolutions Pvt Ltd, B. Braun SE, Baxter International, Inc., Becton, Dickinson and Company, Braile Biomedica, Celox Medical by Medtrade Products Ltd., CryoLife, Edwards Lifesciences Corporation, Getinge AB, Labcor Laboratorios Ltda., LeMaitre Vascular, Inc., Obex Medical Limited, Solinas Medical Inc., Terumo Corporation, VUP Medical, a.s., and W. L. Gore & Associates, Inc..

Market Segmentation & Coverage

This research report categorizes the Vascular Patches Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Material, market is studied across Biologic Vascular Patches and Synthetic Vascular Patches.
  • Based on Application, market is studied across Carotid Endarterectomy, Open Repair of Abdominal Aneurysm, Peripheral Vascular Reconstruction, and Vascular Bypass Surgery.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of vascular diseases and clotting disorders
      • 5.1.1.2. Growing need for biocompatible material to reduce the toxicity of medical devices
    • 5.1.2. Restraints
      • 5.1.2.1. Instances of product recall due to reduced reliability of patches
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in tissue engineering and 3D technology
      • 5.1.3.2. Growing interest in stem cell research and the use of stem cell technology for the production of vascular patches
    • 5.1.4. Challenges
      • 5.1.4.1. Regulatory issues concerning the stability of vascular patches
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Vascular Patches Market, by Material

  • 6.1. Introduction
  • 6.2. Biologic Vascular Patches
  • 6.3. Synthetic Vascular Patches

7. Vascular Patches Market, by Application

  • 7.1. Introduction
  • 7.2. Carotid Endarterectomy
  • 7.3. Open Repair of Abdominal Aneurysm
  • 7.4. Peripheral Vascular Reconstruction
  • 7.5. Vascular Bypass Surgery

8. Americas Vascular Patches Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Vascular Patches Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Vascular Patches Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Aegis Lifesciences Private Limited
  • 2. Artivion, Inc
  • 3. AVOMA GROUP
  • 4. Axio Biosolutions Pvt Ltd
  • 5. B. Braun SE
  • 6. Baxter International, Inc.
  • 7. Becton, Dickinson and Company
  • 8. Braile Biomedica
  • 9. Celox Medical by Medtrade Products Ltd.
  • 10. CryoLife
  • 11. Edwards Lifesciences Corporation
  • 12. Getinge AB
  • 13. Labcor Laboratorios Ltda.
  • 14. LeMaitre Vascular, Inc.
  • 15. Obex Medical Limited
  • 16. Solinas Medical Inc.
  • 17. Terumo Corporation
  • 18. VUP Medical, a.s.
  • 19. W. L. Gore & Associates, Inc.

LIST OF FIGURES

  • FIGURE 1. VASCULAR PATCHES MARKET RESEARCH PROCESS
  • FIGURE 2. VASCULAR PATCHES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL VASCULAR PATCHES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL VASCULAR PATCHES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL VASCULAR PATCHES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL VASCULAR PATCHES MARKET SIZE, BY MATERIAL, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL VASCULAR PATCHES MARKET SIZE, BY MATERIAL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL VASCULAR PATCHES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL VASCULAR PATCHES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS VASCULAR PATCHES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS VASCULAR PATCHES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES VASCULAR PATCHES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES VASCULAR PATCHES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC VASCULAR PATCHES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC VASCULAR PATCHES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA VASCULAR PATCHES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA VASCULAR PATCHES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. VASCULAR PATCHES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. VASCULAR PATCHES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. VASCULAR PATCHES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL VASCULAR PATCHES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL VASCULAR PATCHES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL VASCULAR PATCHES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. VASCULAR PATCHES MARKET DYNAMICS
  • TABLE 7. GLOBAL VASCULAR PATCHES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL VASCULAR PATCHES MARKET SIZE, BY BIOLOGIC VASCULAR PATCHES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL VASCULAR PATCHES MARKET SIZE, BY SYNTHETIC VASCULAR PATCHES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL VASCULAR PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL VASCULAR PATCHES MARKET SIZE, BY CAROTID ENDARTERECTOMY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL VASCULAR PATCHES MARKET SIZE, BY OPEN REPAIR OF ABDOMINAL ANEURYSM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL VASCULAR PATCHES MARKET SIZE, BY PERIPHERAL VASCULAR RECONSTRUCTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL VASCULAR PATCHES MARKET SIZE, BY VASCULAR BYPASS SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS VASCULAR PATCHES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS VASCULAR PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS VASCULAR PATCHES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA VASCULAR PATCHES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA VASCULAR PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL VASCULAR PATCHES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL VASCULAR PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA VASCULAR PATCHES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 23. CANADA VASCULAR PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO VASCULAR PATCHES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 25. MEXICO VASCULAR PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES VASCULAR PATCHES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES VASCULAR PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES VASCULAR PATCHES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC VASCULAR PATCHES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC VASCULAR PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC VASCULAR PATCHES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA VASCULAR PATCHES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 33. AUSTRALIA VASCULAR PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA VASCULAR PATCHES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 35. CHINA VASCULAR PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA VASCULAR PATCHES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 37. INDIA VASCULAR PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA VASCULAR PATCHES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 39. INDONESIA VASCULAR PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN VASCULAR PATCHES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 41. JAPAN VASCULAR PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA VASCULAR PATCHES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 43. MALAYSIA VASCULAR PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES VASCULAR PATCHES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 45. PHILIPPINES VASCULAR PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE VASCULAR PATCHES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 47. SINGAPORE VASCULAR PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA VASCULAR PATCHES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 49. SOUTH KOREA VASCULAR PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN VASCULAR PATCHES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 51. TAIWAN VASCULAR PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND VASCULAR PATCHES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 53. THAILAND VASCULAR PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM VASCULAR PATCHES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 55. VIETNAM VASCULAR PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA VASCULAR PATCHES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA VASCULAR PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA VASCULAR PATCHES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK VASCULAR PATCHES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 60. DENMARK VASCULAR PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT VASCULAR PATCHES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 62. EGYPT VASCULAR PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND VASCULAR PATCHES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 64. FINLAND VASCULAR PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE VASCULAR PATCHES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 66. FRANCE VASCULAR PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY VASCULAR PATCHES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 68. GERMANY VASCULAR PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL VASCULAR PATCHES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 70. ISRAEL VASCULAR PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY VASCULAR PATCHES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 72. ITALY VASCULAR PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS VASCULAR PATCHES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 74. NETHERLANDS VASCULAR PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA VASCULAR PATCHES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 76. NIGERIA VASCULAR PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY VASCULAR PATCHES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 78. NORWAY VASCULAR PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND VASCULAR PATCHES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 80. POLAND VASCULAR PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR VASCULAR PATCHES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 82. QATAR VASCULAR PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA VASCULAR PATCHES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 84. RUSSIA VASCULAR PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA VASCULAR PATCHES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 86. SAUDI ARABIA VASCULAR PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA VASCULAR PATCHES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH AFRICA VASCULAR PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN VASCULAR PATCHES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 90. SPAIN VASCULAR PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN VASCULAR PATCHES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 92. SWEDEN VASCULAR PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND VASCULAR PATCHES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 94. SWITZERLAND VASCULAR PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY VASCULAR PATCHES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 96. TURKEY VASCULAR PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES VASCULAR PATCHES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED ARAB EMIRATES VASCULAR PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM VASCULAR PATCHES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED KINGDOM VASCULAR PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. VASCULAR PATCHES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 102. VASCULAR PATCHES MARKET, FPNV POSITIONING MATRIX, 2023